A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer

Manon Delahaye-Sourdeix, Devasena Anantharaman, Maria N Timofeeva, Valérie Gaborieau, Amélie Chabrier, Maxime P Vallée, Pagona Lagiou, Ivana Holcátová, Lorenzo Richiardi, Kristina Kjaerheim, Antonio Agudo, Xavier Castellsagué, Tatiana MacFarlane, Luigi Barzan, Cristina Canova, Nalin S Thakker, David I Conway, Ariana Znaor, Claire M Healy, Wolfgang AhrensDavid Zaridze, Neonilia Szeszenia-Dabrowska, Jolanta Lissowska, Eleonora Fabianova, Ioan Nicolae Mates, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Maria Paula Curado, Sergio Koifman, Ana Menezes, Victor Wünsch-Filho, José Eluf-Neto, Paolo Boffetta, Leticia Fernández Garrote, Jerry Polesel, Marcin Lener, Ewa Jaworowska, Jan Lubiński, Stefania Boccia, Thangarajan Rajkumar, Tanuja A Samant, Manoj B Mahimkar, Keitaro Matsuo, Silvia Franceschi, Graham Byrnes, Paul Brennan, James D McKay

Research output: Contribution to journalArticle

19 Citations (Scopus)
5 Downloads (Pure)

Abstract

Deleterious BRCA2 genetic variants markedly increase risk of developing breast cancer. A rare truncating BRCA2 genetic variant, rs11571833 (K3326X), has been associated with a 2.5-fold risk of lung squamous cell carcinoma but only a modest 26% increase in breast cancer risk. We analyzed the association between BRCA2 SNP rs11571833 and upper aerodigestive tract (UADT) cancer risk with multivariable unconditional logistic regression adjusted by sex and combinations of study and country for 5942 UADT squamous cell carcinoma case patients and 8086 control patients from nine different studies. All statistical tests were two-sided. rs11571833 was associated with UADT cancers (odds ratio = 2.53, 95% confidence interval = 1.89 to 3.38, P = 3x10(-10)) and was present in European, Latin American, and Indian populations but extremely rare in Japanese populations. The association appeared more apparent in smokers (current or former) compared with never smokers (P het = .026). A robust association between a truncating BRCA2 variant and UADT cancer risk suggests that treatment strategies orientated towards BRCA2 mutations may warrant further investigation in UADT tumors.

Original languageEnglish
Article numberdjv037
Number of pages4
JournalJournal of the National Cancer Institute
Volume107
Issue number5
Early online date2 Apr 2015
DOIs
Publication statusPublished - 1 May 2015

Fingerprint

Genetic Predisposition to Disease
Neoplasms
Squamous Cell Carcinoma
Breast Neoplasms
North American Indians
Population
Single Nucleotide Polymorphism
Logistic Models
Odds Ratio
Confidence Intervals
Lung
Mutation
Therapeutics

Cite this

Delahaye-Sourdeix, M., Anantharaman, D., Timofeeva, M. N., Gaborieau, V., Chabrier, A., Vallée, M. P., ... McKay, J. D. (2015). A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. Journal of the National Cancer Institute, 107(5), [djv037]. https://doi.org/10.1093/jnci/djv037

A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. / Delahaye-Sourdeix, Manon; Anantharaman, Devasena; Timofeeva, Maria N; Gaborieau, Valérie; Chabrier, Amélie; Vallée, Maxime P; Lagiou, Pagona; Holcátová, Ivana; Richiardi, Lorenzo; Kjaerheim, Kristina; Agudo, Antonio; Castellsagué, Xavier; MacFarlane, Tatiana; Barzan, Luigi; Canova, Cristina; Thakker, Nalin S; Conway, David I; Znaor, Ariana; Healy, Claire M; Ahrens, Wolfgang; Zaridze, David; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Fabianova, Eleonora; Mates, Ioan Nicolae; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; Curado, Maria Paula; Koifman, Sergio; Menezes, Ana; Wünsch-Filho, Victor; Eluf-Neto, José; Boffetta, Paolo; Fernández Garrote, Leticia; Polesel, Jerry; Lener, Marcin; Jaworowska, Ewa; Lubiński, Jan; Boccia, Stefania; Rajkumar, Thangarajan; Samant, Tanuja A; Mahimkar, Manoj B; Matsuo, Keitaro; Franceschi, Silvia; Byrnes, Graham; Brennan, Paul; McKay, James D.

In: Journal of the National Cancer Institute, Vol. 107, No. 5, djv037, 01.05.2015.

Research output: Contribution to journalArticle

Delahaye-Sourdeix, M, Anantharaman, D, Timofeeva, MN, Gaborieau, V, Chabrier, A, Vallée, MP, Lagiou, P, Holcátová, I, Richiardi, L, Kjaerheim, K, Agudo, A, Castellsagué, X, MacFarlane, T, Barzan, L, Canova, C, Thakker, NS, Conway, DI, Znaor, A, Healy, CM, Ahrens, W, Zaridze, D, Szeszenia-Dabrowska, N, Lissowska, J, Fabianova, E, Mates, IN, Bencko, V, Foretova, L, Janout, V, Curado, MP, Koifman, S, Menezes, A, Wünsch-Filho, V, Eluf-Neto, J, Boffetta, P, Fernández Garrote, L, Polesel, J, Lener, M, Jaworowska, E, Lubiński, J, Boccia, S, Rajkumar, T, Samant, TA, Mahimkar, MB, Matsuo, K, Franceschi, S, Byrnes, G, Brennan, P & McKay, JD 2015, 'A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer', Journal of the National Cancer Institute, vol. 107, no. 5, djv037. https://doi.org/10.1093/jnci/djv037
Delahaye-Sourdeix M, Anantharaman D, Timofeeva MN, Gaborieau V, Chabrier A, Vallée MP et al. A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. Journal of the National Cancer Institute. 2015 May 1;107(5). djv037. https://doi.org/10.1093/jnci/djv037
Delahaye-Sourdeix, Manon ; Anantharaman, Devasena ; Timofeeva, Maria N ; Gaborieau, Valérie ; Chabrier, Amélie ; Vallée, Maxime P ; Lagiou, Pagona ; Holcátová, Ivana ; Richiardi, Lorenzo ; Kjaerheim, Kristina ; Agudo, Antonio ; Castellsagué, Xavier ; MacFarlane, Tatiana ; Barzan, Luigi ; Canova, Cristina ; Thakker, Nalin S ; Conway, David I ; Znaor, Ariana ; Healy, Claire M ; Ahrens, Wolfgang ; Zaridze, David ; Szeszenia-Dabrowska, Neonilia ; Lissowska, Jolanta ; Fabianova, Eleonora ; Mates, Ioan Nicolae ; Bencko, Vladimir ; Foretova, Lenka ; Janout, Vladimir ; Curado, Maria Paula ; Koifman, Sergio ; Menezes, Ana ; Wünsch-Filho, Victor ; Eluf-Neto, José ; Boffetta, Paolo ; Fernández Garrote, Leticia ; Polesel, Jerry ; Lener, Marcin ; Jaworowska, Ewa ; Lubiński, Jan ; Boccia, Stefania ; Rajkumar, Thangarajan ; Samant, Tanuja A ; Mahimkar, Manoj B ; Matsuo, Keitaro ; Franceschi, Silvia ; Byrnes, Graham ; Brennan, Paul ; McKay, James D. / A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer. In: Journal of the National Cancer Institute. 2015 ; Vol. 107, No. 5.
@article{e53a348070b14ca5839d8b7e7f89a2e8,
title = "A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer",
abstract = "Deleterious BRCA2 genetic variants markedly increase risk of developing breast cancer. A rare truncating BRCA2 genetic variant, rs11571833 (K3326X), has been associated with a 2.5-fold risk of lung squamous cell carcinoma but only a modest 26{\%} increase in breast cancer risk. We analyzed the association between BRCA2 SNP rs11571833 and upper aerodigestive tract (UADT) cancer risk with multivariable unconditional logistic regression adjusted by sex and combinations of study and country for 5942 UADT squamous cell carcinoma case patients and 8086 control patients from nine different studies. All statistical tests were two-sided. rs11571833 was associated with UADT cancers (odds ratio = 2.53, 95{\%} confidence interval = 1.89 to 3.38, P = 3x10(-10)) and was present in European, Latin American, and Indian populations but extremely rare in Japanese populations. The association appeared more apparent in smokers (current or former) compared with never smokers (P het = .026). A robust association between a truncating BRCA2 variant and UADT cancer risk suggests that treatment strategies orientated towards BRCA2 mutations may warrant further investigation in UADT tumors.",
author = "Manon Delahaye-Sourdeix and Devasena Anantharaman and Timofeeva, {Maria N} and Val{\'e}rie Gaborieau and Am{\'e}lie Chabrier and Vall{\'e}e, {Maxime P} and Pagona Lagiou and Ivana Holc{\'a}tov{\'a} and Lorenzo Richiardi and Kristina Kjaerheim and Antonio Agudo and Xavier Castellsagu{\'e} and Tatiana MacFarlane and Luigi Barzan and Cristina Canova and Thakker, {Nalin S} and Conway, {David I} and Ariana Znaor and Healy, {Claire M} and Wolfgang Ahrens and David Zaridze and Neonilia Szeszenia-Dabrowska and Jolanta Lissowska and Eleonora Fabianova and Mates, {Ioan Nicolae} and Vladimir Bencko and Lenka Foretova and Vladimir Janout and Curado, {Maria Paula} and Sergio Koifman and Ana Menezes and Victor W{\"u}nsch-Filho and Jos{\'e} Eluf-Neto and Paolo Boffetta and {Fern{\'a}ndez Garrote}, Leticia and Jerry Polesel and Marcin Lener and Ewa Jaworowska and Jan Lubiński and Stefania Boccia and Thangarajan Rajkumar and Samant, {Tanuja A} and Mahimkar, {Manoj B} and Keitaro Matsuo and Silvia Franceschi and Graham Byrnes and Paul Brennan and McKay, {James D}",
note = "{\circledC} The Author 2015. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Funding This work was supported the National Institutes of Health (R01CA092039 05/05S1) and the National Institute of Dental and Craniofacial Research (1R03DE020116). Notes The authors thank all of the participants who took part in this research and the funders and technical staff who made this study possible. We acknowledge and thank Simone Benhamou (INSERM, France) for sample contributions. We also acknowledge and thank The Cancer Genome Atlas initiative, whose data contributed heavily to this study.",
year = "2015",
month = "5",
day = "1",
doi = "10.1093/jnci/djv037",
language = "English",
volume = "107",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - A rare truncating BRCA2 variant and genetic susceptibility to upper aerodigestive tract cancer

AU - Delahaye-Sourdeix, Manon

AU - Anantharaman, Devasena

AU - Timofeeva, Maria N

AU - Gaborieau, Valérie

AU - Chabrier, Amélie

AU - Vallée, Maxime P

AU - Lagiou, Pagona

AU - Holcátová, Ivana

AU - Richiardi, Lorenzo

AU - Kjaerheim, Kristina

AU - Agudo, Antonio

AU - Castellsagué, Xavier

AU - MacFarlane, Tatiana

AU - Barzan, Luigi

AU - Canova, Cristina

AU - Thakker, Nalin S

AU - Conway, David I

AU - Znaor, Ariana

AU - Healy, Claire M

AU - Ahrens, Wolfgang

AU - Zaridze, David

AU - Szeszenia-Dabrowska, Neonilia

AU - Lissowska, Jolanta

AU - Fabianova, Eleonora

AU - Mates, Ioan Nicolae

AU - Bencko, Vladimir

AU - Foretova, Lenka

AU - Janout, Vladimir

AU - Curado, Maria Paula

AU - Koifman, Sergio

AU - Menezes, Ana

AU - Wünsch-Filho, Victor

AU - Eluf-Neto, José

AU - Boffetta, Paolo

AU - Fernández Garrote, Leticia

AU - Polesel, Jerry

AU - Lener, Marcin

AU - Jaworowska, Ewa

AU - Lubiński, Jan

AU - Boccia, Stefania

AU - Rajkumar, Thangarajan

AU - Samant, Tanuja A

AU - Mahimkar, Manoj B

AU - Matsuo, Keitaro

AU - Franceschi, Silvia

AU - Byrnes, Graham

AU - Brennan, Paul

AU - McKay, James D

N1 - © The Author 2015. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com Funding This work was supported the National Institutes of Health (R01CA092039 05/05S1) and the National Institute of Dental and Craniofacial Research (1R03DE020116). Notes The authors thank all of the participants who took part in this research and the funders and technical staff who made this study possible. We acknowledge and thank Simone Benhamou (INSERM, France) for sample contributions. We also acknowledge and thank The Cancer Genome Atlas initiative, whose data contributed heavily to this study.

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Deleterious BRCA2 genetic variants markedly increase risk of developing breast cancer. A rare truncating BRCA2 genetic variant, rs11571833 (K3326X), has been associated with a 2.5-fold risk of lung squamous cell carcinoma but only a modest 26% increase in breast cancer risk. We analyzed the association between BRCA2 SNP rs11571833 and upper aerodigestive tract (UADT) cancer risk with multivariable unconditional logistic regression adjusted by sex and combinations of study and country for 5942 UADT squamous cell carcinoma case patients and 8086 control patients from nine different studies. All statistical tests were two-sided. rs11571833 was associated with UADT cancers (odds ratio = 2.53, 95% confidence interval = 1.89 to 3.38, P = 3x10(-10)) and was present in European, Latin American, and Indian populations but extremely rare in Japanese populations. The association appeared more apparent in smokers (current or former) compared with never smokers (P het = .026). A robust association between a truncating BRCA2 variant and UADT cancer risk suggests that treatment strategies orientated towards BRCA2 mutations may warrant further investigation in UADT tumors.

AB - Deleterious BRCA2 genetic variants markedly increase risk of developing breast cancer. A rare truncating BRCA2 genetic variant, rs11571833 (K3326X), has been associated with a 2.5-fold risk of lung squamous cell carcinoma but only a modest 26% increase in breast cancer risk. We analyzed the association between BRCA2 SNP rs11571833 and upper aerodigestive tract (UADT) cancer risk with multivariable unconditional logistic regression adjusted by sex and combinations of study and country for 5942 UADT squamous cell carcinoma case patients and 8086 control patients from nine different studies. All statistical tests were two-sided. rs11571833 was associated with UADT cancers (odds ratio = 2.53, 95% confidence interval = 1.89 to 3.38, P = 3x10(-10)) and was present in European, Latin American, and Indian populations but extremely rare in Japanese populations. The association appeared more apparent in smokers (current or former) compared with never smokers (P het = .026). A robust association between a truncating BRCA2 variant and UADT cancer risk suggests that treatment strategies orientated towards BRCA2 mutations may warrant further investigation in UADT tumors.

U2 - 10.1093/jnci/djv037

DO - 10.1093/jnci/djv037

M3 - Article

C2 - 25838448

VL - 107

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 5

M1 - djv037

ER -